Joshua Yang

Co-Founder & CEO at Glyphic Biotechnologies
On the record

Joshua is the co-founder and CEO of Glyphic Biotechnologies, a VC-funded biotechnology startup commercializing a next-generation protein sequencing platform. His first startup Nephrosant has raised over $22M in funding to commercialize a low-cost, non-invasive diagnostic assay for kidney injury.

Recent Quotes
Sign up to view all
  • The activity in this space is insane. My co-founder and I really want to be the next Illumina or 10X Genomics — we really want to be that leader in proteomics.

    30 July 2021
Sign up to view all